Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innocan Pharma LtdfiledCriticalInnocan Pharma Ltd
Priority to ARP200102868ApriorityCriticalpatent/AR122320A1/en
Publication of AR122320A1publicationCriticalpatent/AR122320A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
En la presente invención se describen composiciones para uso tópico que comprenden agentes activos para proporcionar alivio del dolor. Las composiciones comprenden una sal de magnesio, un cannabinoide y al menos un agente analgésico tópico adicional. Adicionalmente, se describen métodos para el tratamiento del dolor, que comprenden la administración a una persona que lo necesite de una composición que comprende una cantidad farmacéuticamente efectiva de un cannabinoide, una sal de magnesio y, al menos, uno de salicilato de metilo y metanol.Compositions for topical use comprising active agents for providing pain relief are described herein. The compositions comprise a magnesium salt, a cannabinoid, and at least one additional topical analgesic agent. Additionally, methods for the treatment of pain are described, which comprise the administration to a person in need of a composition that comprises a pharmaceutically effective amount of a cannabinoid, a magnesium salt and, at least, one of methyl salicylate and methanol. .
ARP200102868A2020-10-162020-10-16
TOPICAL COMPOSITIONS FOR THE RELIEF OF PAIN
AR122320A1
(en)
USE OF A SELECTED RETINOID COMPONENT BETWEEN THE GROUP FORMED BY ACTIVE RETINOID AGENTS, PRETURSORS OF ACTIVE RETINOID AGENTS AND MIXTURES OF THE SAME, TO PREPARE A PHARMACEUTICAL COMPOSITION